XOMA Royalty (XOMA) Return on Sales (2011 - 2026)

XOMA Royalty's (XOMA) quarterly Return on Sales came in at 0.0% in Q1 2026, little changed year-on-year from 0.0% in Q1 2025, and up 159.97% quarter-over-quarter from 0.01% in Q4 2025.

XOMA Royalty (XOMA) Return on Sales (2011 - 2026) Analysis & Trends

XOMA Royalty has disclosed Return on Sales across 16 years of filings, most recently posting 0.0% for Q1 2026.

  • Return on Sales for Q1 2026 came in at 0.0%, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.0% (up 2.0% YoY), and the FY2025 annual result was 0.0%, changed 0.0% from the prior year.
  • Return on Sales came in at 0.0% for Q1 2026 at XOMA Royalty, up from 0.01% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.62% in Q3 2025 to a low of 6.9% in Q3 2024.
  • The 5-year median for Return on Sales is 0.04% (2022), against an average of 0.4%.
  • Across the five-year window, Return on Sales slumped 683 bps in 2024 and jumped 752 bps in 2025, its largest moves.
  • XOMA Royalty's Return on Sales stood at 0.04% in 2022, then slumped by 160 bps to 0.11% in 2023, then soared by 280 bps to 0.2% in 2024, then plunged by 103 bps to 0.01% in 2025, then jumped by 160 bps to 0.0% in 2026.
  • The last three Return on Sales figures came in at 0.0% (Q1 2026), 0.01% (Q4 2025), and 0.62% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - -
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - -
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - -
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn 0.00%
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - -
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - 0.00%
7 Psyence Biomedical 238.34 Bn 238.33 Bn - -
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn 0.00%
9 Abivax 95.45 Bn 95.45 Bn - -
10 XOMA Royalty 5.52 Mn -60.56 Mn - 0.00%

Historic Data

Download Data
DateValue
Mar 31, 2026 0.00%
Dec 31, 2025 -0.01%
Sep 30, 2025 0.62%
Jun 30, 2025 0.00%
Mar 31, 2025 0.01%
Dec 31, 2024 0.20%
Sep 30, 2024 -6.90%
Jun 30, 2024 -0.03%
Mar 31, 2024 -0.07%
Dec 31, 2023 -0.11%
Sep 30, 2023 -0.07%
Jun 30, 2023 -0.09%
Mar 31, 2023 -0.23%
Dec 31, 2022 -0.04%
Sep 30, 2022 -0.10%
Jun 30, 2022 -0.05%
Mar 31, 2022 -0.01%
Dec 31, 2021 1.49%
Sep 30, 2021 -0.05%
Jun 30, 2021 -0.02%